S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: Acasti Pharma Inc [ACST]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间27 Apr 2024 @ 04:00

-2.03% $ 2.90

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases...

Stats
今日成交量 3 820.00
平均成交量 25 968.00
市值 27.26M
EPS $-0.300 ( 2024-02-13 )
下一个收益日期 ( $-0.350 ) 2024-06-28
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.510
ATR14 $0.0430 (1.48%)
Insider Trading
Date Person Action Amount type
2024-01-05 Delaversano Robert J Sell 42 000 Stock Options (Right to Buy)
2023-12-19 Kavuru Vimal Buy 10 000 Stock Options (Right to Buy)
2023-12-19 Kottayil George Buy 22 500 Stock Options (Right to Buy)
2023-12-19 Neugeboren Edward Buy 22 500 Stock Options (Right to Buy)
2023-12-19 Davis A Brian Buy 22 500 Stock Options (Right to Buy)
INSIDER POWER
88.62
Last 64 transactions
Buy: 4 252 386 | Sell: 2 858 533

Acasti Pharma Inc 相关性

10 最正相关
RMRM0.959
IKT0.947
CRDO0.926
AGFY0.92
ELTK0.916
MRVL0.906
UCTT0.904
NTUS0.902
BLZE0.901
NWSA0.9
10 最负相关
NEXT-0.895
ECOR-0.889
HFBL-0.889
IRTC-0.887
MTEK-0.882
HIBB-0.88
HALL-0.876
WTFC-0.876
EYEG-0.875
MLAB-0.874

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Acasti Pharma Inc 财务报表

Annual 2022
营收: $0
毛利润: $-52.16M (0.00 %)
EPS: $-5.71
FY 2022
营收: $0
毛利润: $-52.16M (0.00 %)
EPS: $-5.71
FY 2022
营收: $0
毛利润: $-15.59M (0.00 %)
EPS: $-0.270
FY 2021
营收: $196 000
毛利润: $120 000 (61.22 %)
EPS: $-1.360

Financial Reports:

No articles found.

Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。